Herpes Zoster Occurs More Frequently in Certain Organ Transplant Recipients


Herpes zoster (HZ) incidence and severity among patients who received solid organ transplants (SOTs) are most pronounced among those who received heart or lung transplantation, older patients, and in the absence of cytomegalovirus (CMV) prophylaxis, according to a study published in Frontiers in Immunology. Although it was previously known that HZ incidence and HZ-related complications occur more frequently and with higher severity in solid organ transplant recipients, numbers varied extensively between studies.

To conduct the study, the investigators reviewed the records of 1033 transplant recipients following their first heart (HTx), lung (LuTx), liver (LiTx), or kidney (KTx) transplantation between 2000 and 2014. These records were analyzed for varicella zoster virus (VZV) polymerase chain reaction (PCR), clinical indications of HZ, and other complications.

Across all patient records reviewed, 108 study participants (10.5%) were diagnosed with HZ. Of these patients, 36 were HTx recipients, 17 were LuTx recipients, 15 were LiTx recipients, and 40 were KTx recipients. This translated to 17% of HTx recipients, 14% of LuRx recipients, 6% of LiTx recipients, and 9.2% of KTx recipients being diagnosed with HZ.

Significant risk factors, determined via multivariable analysis, included patients being aged 50 years or older, which type of organ transplant was received, reception of CMV prophylaxis, and the type of anti-rejection therapy given. Out of the 108 patients diagnosed with HZ, 33 (31%) experienced complications, including post-herpetic neuralgia, disseminated disease, and cranial nerve involvement.

“In summary, this study shows that incidence of HZ is high after organ transplantation with severe complications,” the authors write in the study. “The incidence of HZ after HTx or LuTx is significantly higher than after LiTx or KTx. Use of CMV prophylaxis significantly decreases HZ incidence. A rational method to prevent HZ after organ transplantation might be to use CMV prophylaxis, and in our opinion booster vaccination in seropositive transplant candidates is advisable.”

According to the investigators, vaccination against HZ has been shown to be effective in preventing VZV infection in otherwise healthy elderly individuals. Although the live attenuated vaccine cannot be given to patients receiving immunosuppressive medication due to the risk of induced infection, the subunit vaccine, which does not contain live virus, can be administered to this population. The authors note that more studies are necessary to confirm the efficacy of this vaccine in transplant recipients.


Kho MML, Roest S, Bovée DM, et al. Herpes zoster in solid organ transplantation: incidence and risk factors. Front Immunol. 2021; 12: 645718. Published online 2021 Mar 18. doi:10.3389/fimmu.2021.645718

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii | stock.adobe.com
Pharmacy Interior | Image Credit: Tyler Olson - stock.adobe.com
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi - stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/peopleimages.com | stock.adobe.com
Image credit: fidaolga - stock.adobe.com
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund | stock.adobe.com
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi - stock.adobe.com
© 2023 MJH Life Sciences

All rights reserved.